Sale!

IMPAD1 Gene Chondrodysplasia with Joint Dislocations GPAPP Type NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The IMPAD1 Gene Chondrodysplasia with Joint Dislocations GPAPP Type NGS Genetic DNA Test is a specialized diagnostic tool that identifies mutations in the IMPAD1 gene responsible for a rare skeletal disorder characterized by abnormal bone development and recurrent joint dislocations. This comprehensive test utilizes Next-Generation Sequencing technology to provide precise genetic analysis, enabling accurate diagnosis and personalized treatment strategies. Patients experiencing skeletal abnormalities, joint instability, or developmental delays benefit from this advanced testing approach. The test costs $500 USD and provides results within 3-4 weeks, offering crucial insights for affected individuals and their families.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

IMPAD1 Gene Chondrodysplasia with Joint Dislocations GPAPP Type NGS Genetic DNA Test

Understanding IMPAD1 Gene Chondrodysplasia

IMPAD1 Gene Chondrodysplasia with Joint Dislocations GPAPP Type represents a rare genetic disorder affecting skeletal development and joint stability. This condition, caused by mutations in the IMPAD1 gene, disrupts normal bone growth and connective tissue formation, leading to characteristic physical features and recurrent joint dislocations. Our advanced NGS Genetic DNA Test provides comprehensive analysis to identify these genetic variations, offering crucial diagnostic information for affected individuals and their families.

What Does This Test Measure?

The IMPAD1 Gene Chondrodysplasia NGS Genetic DNA Test specifically targets and analyzes the IMPAD1 gene using cutting-edge Next-Generation Sequencing technology. This comprehensive assessment detects:

  • Pathogenic mutations in the IMPAD1 gene responsible for GPAPP type chondrodysplasia
  • Genetic variations affecting skeletal development and joint stability
  • Inheritance patterns and carrier status information
  • Specific nucleotide changes impacting bone and connective tissue formation

Who Should Consider This Test?

This specialized genetic test is recommended for individuals presenting with:

  • Recurrent joint dislocations or joint hypermobility
  • Abnormal skeletal development and growth patterns
  • Characteristic facial features associated with skeletal dysplasias
  • Family history of similar skeletal abnormalities
  • Developmental delays related to musculoskeletal issues
  • Unexplained short stature with joint complications

Benefits of IMPAD1 Genetic Testing

Undergoing the IMPAD1 Gene Chondrodysplasia NGS Genetic DNA Test provides numerous advantages:

  • Accurate Diagnosis: Confirms or rules out IMPAD1-related chondrodysplasia with high precision
  • Personalized Treatment: Enables targeted management strategies for joint stability and skeletal health
  • Family Planning: Provides crucial information for genetic counseling and reproductive decisions
  • Early Intervention: Facilitates timely implementation of supportive therapies and monitoring
  • Comprehensive Analysis: Utilizes advanced NGS technology for thorough genetic assessment

Understanding Your Test Results

Your IMPAD1 Gene Chondrodysplasia test results will provide clear genetic information:

  • Positive Result: Indicates the presence of IMPAD1 gene mutations associated with GPAPP type chondrodysplasia
  • Negative Result: Suggests no detectable mutations in the IMPAD1 gene related to this condition
  • Variant of Uncertain Significance: Identifies genetic changes requiring further clinical correlation
  • Carrier Status: Determines if you carry the genetic mutation without showing symptoms

Our genetic counselors will help interpret your results and provide guidance on next steps for management and family planning.

Test Details and Pricing

Test Component Details
Test Name IMPAD1 Gene Chondrodysplasia with Joint Dislocations GPAPP Type NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Specialty Pediatrics
Department Genetics
Method NGS Technology
Disease Type Dysmorphology

Pre-Test Instructions

Before undergoing the IMPAD1 Gene Chondrodysplasia test, please ensure:

  • Complete clinical history documentation of the patient
  • Participation in a genetic counseling session
  • Preparation of a detailed pedigree chart documenting family members affected by similar conditions
  • Discussion of testing implications and potential outcomes with healthcare providers

Nationwide Testing Availability

We proudly offer the IMPAD1 Gene Chondrodysplasia with Joint Dislocations GPAPP Type NGS Genetic DNA Test across the United States. Our state-of-the-art testing facilities are conveniently located in major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more locations nationwide.

Take Control of Your Genetic Health Today

Don’t let uncertainty about skeletal and joint conditions affect your quality of life. Our IMPAD1 Gene Chondrodysplasia NGS Genetic DNA Test provides the clarity you need for informed healthcare decisions. With our discounted price of $500 USD and comprehensive genetic analysis, you can gain valuable insights into your genetic makeup and potential health risks.

Ready to schedule your test? Contact us today at +1(267) 388-9828 or book your appointment online. Our genetic specialists are available to answer your questions and guide you through the testing process.